Hospi Closes Funding Round with Investments from Post-Acute Industry Leaders

New investors include industry leaders Tom Maxwell, Bryan Wolfe, and Matt McMurphy. Their involvement validates the potential of the Macy Catheter to enhance post-acute care nationwide.

Tom Maxwell is well-situated to evaluate the impact and contribution that Hospi can make to post-acute healthcare from his perch as Chairman and Co-Founder of Maxwell Healthcare Associates (a business consulting firm specialized in home health and hospice), as an Operating Partner with the Vistria Group, as Non-Executive Chairman of the Board at Medalogix, as a strategic advisor and investor at Trella Health, and as a board member of several home health and hospice focused entities. Tom invested in Hospi via his role as Co-Chief Executive Officer at Maxwell Investment Partners along with his business partner Jennifer Maxwell.

“We invested in Hospi because I appreciate the value of being able to quickly palliate patients in the setting of their choice,” said Tom Maxwell. “I trust the team, I like the economics, and, as in all our investments, we believe we can make a difference; we intend to roll up our sleeves to help.”

Bryan Wolfe–who co-founded and built national hospice and home health provider Traditions Health from a single office in College Station, Texas in 2008 to over 75 offices across 14 states as its CEO prior to his retirement in 2021–is representing the new investors on Hospi’s Board of Directors.

Bryan said, “I decided to invest and serve on Hospi’s Board because providing seriously ill patients and their families a solution to pain relief and discomfort associated with end of life care is very important to me. No one should have to die in pain or discomfort. I think every hospice in the country will eventually adopt the Macy Catheter.”

Matt McMurphy is a healthcare investor with direct operational experience across various executive-level functions within the healthcare industry. He is President/CEO of Reliant at Home in Texas, an active board member at Acacia Health in California, founder and partner at Lakewood Healthcare Capital, and was formerly Vice President of Strategy and General Counsel of Encompass Home Health & Hospice. The diversity of McMurphy’s expertise makes him an invaluable source of insight as Hospi continues on its mission to enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

Igal Ladabaum, Hospi’s co-founder and CEO, said “We are delighted to welcome post-acute leaders Tom, Bryan, and Matt to the Hospi family, and are humbled to have been able to attract contributors of their caliber. We look forward to working together to bring the benefits of our medication administration technology to many more patients and caregivers. The world deserves this technology at scale.”

About Hospi Corporation
Hospi Corporation was founded to innovate practical medical devices that improve quality of life for both patients and their caregivers.

For more information, visit https://www.hospicorp.com/.

About the Macy Catheter
Hospi Corporation’s flagship product, the Macy Catheter, is used by leading post-acute programs in the United States (i.e. home health, hospice, palliative care, and skilled nursing) to administer fluids and medications when the oral route is compromised– in any setting and without sterile technique.

For more information, visit https://www.macycatheter.com/.

For Media Inquiries
Contact Molly Seaman at molly.seaman@hospicorp.com or 510-270-4355 x10.